Global IL-6 Inhibitors Market Report By Phase (Filed: Drug Profiles, Phase III: Drug Profiles, Phase II: Drug Profiles, Pre-Clinical: Drug Profiles, Discovery: Drug Profiles), By Application (Inflammation, Infection, Autoimmune Disorders, Cardiovascular Diseases, Cancers, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global IL-6 Inhibitors Market Report
Brand: Value Market Research
SKU: Biotechnology
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212815

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for IL-6 Inhibitors Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028. Whereas with regards to volume, the market was calculated XX Kilo Tons in 2021 and foreseen to touch XX Kilo Tons by 2028 with a CAGR of XX% during 2022-2028.

Interleukin-6 (IL-6) belongs to a cytokine family which consists of polypeptide cytokines with a four–alpha-helix structure and a molecular mass of 21 to 28 kDa. It is an endogenous chemical that is active in B cell maturation and inflammation. It is an essential mediator of fever and the acute phase response. It is produced in response to infections and tissue injuries, either acute or chronic, and is relevant to many inflammatory diseases and cancers.

Market Dynamics

The global IL-6 inhibitors market is driven by growing R&D research and FDA approval. The rising burden of inflammation, infection, autoimmune disorders, cardiovascular diseases, and cancers is augmenting the market growth. Currently, three anti-IL-6 are approved for therapy: tocilizumab, siltuximab, and sarilumab, while several agents are in clinical trials: olokizumab, elsilimomab, sirukumab, vilimab, and CPSI-2364. There is also some evidence that Interleukin-6 can be used as an inflammatory marker for severe COVID-19 infection with poor prognosis, on the broader coronavirus pandemic. Favorable results from study and trials will benefit the market.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of IL-6 inhibitors.

Market Segmentation

The entire IL-6 inhibitors market has been sub-categorized into phase and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Phase

Filed: Drug Profiles
Phase III: Drug Profiles
Phase II: Drug Profiles
Pre-Clinical: Drug Profiles
Discovery: Drug Profiles

By Application

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for IL-6 inhibitors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global IL-6 Inhibitors Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the IL-6 inhibitors market include Chugai Pharmaceutical Co. Ltd., GlaxoSmithKline Plc, Vitaeris Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., Sanofi-aventis Groupe, Janssen Global Services LLC, Novimmune SA, UCB Pharma. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Il-6 Inhibitors Market
       2.2. Global Il-6 Inhibitors Market Snapshot

3 . IL-6 INHIBITORS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Il-6 Inhibitors Market
       3.3. Market Restraints of Il-6 Inhibitors Market
       3.4. Opportunities of Il-6 Inhibitors Market
       3.5. Trends of Il-6 Inhibitors Market
       3.6. Porter’s Five Force Analysis of Il-6 Inhibitors Market
       3.7. Il-6 Inhibitors Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Phase
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Il-6 Inhibitors Value Chain Analysis
       4.2. Il-6 Inhibitors Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Il-6 Inhibitors Raw Material Manufactures List
           4.2.3. Price Trend of Il-6 Inhibitors Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Il-6 Inhibitors Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Il-6 Inhibitors Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Il-6 Inhibitors Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Il-6 Inhibitors Market

6 . GLOBAL IL-6 INHIBITORS MARKET ANALYSIS BY PHASE
       6.1 Overview by Phase
       6.2 Historical Data 2015-2018
       6.3 Global Il-6 Inhibitors Market Analysis by Phase
       6.4 Market Analysis of Filed: Drug Profiles by Regions
       6.6 Market Analysis of Phase III: Drug Profiles by Regions
       6.5 Market Analysis of Phase II: Drug Profiles by Regions
       6.7 Market Analysis of Pre-Clinical: Drug Profiles by Regions
       6.8 Market Analysis of Discovery: Drug Profiles by Regions

7 . GLOBAL IL-6 INHIBITORS MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical Data 2015-2018
       7.3 Global Il-6 Inhibitors Market Analysis by Application
       7.4 Market Analysis of Inflammation by Regions
       7.5 Market Analysis of Infection by Regions
       7.6 Market Analysis of Autoimmune Disorders by Regions
       7.7 Market Analysis of Cardiovascular Diseases by Regions
       7.8 Market Analysis of Cancers by Regions
       7.9 Market Analysis of Others by Regions

8 . GLOBAL IL-6 INHIBITORS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview and Historic Data
           8.3.2. North America Il-6 Inhibitors Market Estimate By Market Segment
           8.3.3. North America Il-6 Inhibitors Market Estimate By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview and Historic Data
           8.4.2. Europe Il-6 Inhibitors Market Estimate by Market Segment
           8.4.3. Europe Il-6 Inhibitors Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview and Historic Data
           8.5.2. Asia Pacific Il-6 Inhibitors Market Estimate by Market Segment
           8.5.3. Asia Pacific Il-6 Inhibitors Market Estimate by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
          8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview and Historic Data
           8.6.2. Latin America Il-6 Inhibitors Market Estimate by Market Segment
           8.6.3. Latin America Il-6 Inhibitors Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview and Historic Data
           8.7.2. Middle East & Africa Il-6 Inhibitors Market Estimate by Market Segment
           8.7.3. Middle East & Africa Il-6 Inhibitors Market Estimate by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE IL-6 INHIBITORS COMPANIES
       9.1. Il-6 Inhibitors Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF IL-6 INHIBITORS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Chugai Pharmaceutical Co. Ltd.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. GlaxoSmithKline Plc
           10.4.1. Company Overview
          10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Vitaeris Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. F. Hoffmann-La Roche Ltd.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Regeneron Pharmaceuticals Inc.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Sanofi-aventis Groupe
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Janssen Global Services LLC
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Novimmune SA
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. UCB Pharma
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Il-6 Inhibitors Report
Market Research Process
Market Research Methodology
Global Il-6 Inhibitors Market Size, by Region (2019)
Porters Five Forces Analysis
Market Attractiveness Analysis by Phase
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Il-6 Inhibitors Market Analysis by Phase
Global Il-6 Inhibitors Market Analysis in Filed: Drug Profiles by Region
Global Il-6 Inhibitors Market Analysis in Phase III: Drug Profiles by Region
Global Il-6 Inhibitors Market Analysis in Phase II: Drug Profiles by Region
Global Il-6 Inhibitors Market Analysis in Pre-Clinical: Drug Profiles by Region
Global Il-6 Inhibitors Market Analysis in Discovery: Drug Profiles by Region
Global Il-6 Inhibitors Market Analysis by Application
Global Il-6 Inhibitors Market Analysis in Inflammation by Region
Global Il-6 Inhibitors Market Analysis in Infection by Region
Global Il-6 Inhibitors Market Analysis in Autoimmune Disorders by Region
Global Il-6 Inhibitors Market Analysis in Cardiovascular Diseases by Region
Global Il-6 Inhibitors Market Analysis in Cancers by Region
Global Il-6 Inhibitors Market Analysis in Others by Region
Global Il-6 Inhibitors Market by Volume And Revenue
North America Il-6 Inhibitors Market by Volume And Revenue
Europe Il-6 Inhibitors Market by Volume And Revenue
Asia Pacific Il-6 Inhibitors Market by Volume And Revenue
Latin America Il-6 Inhibitors Market by Volume And Revenue
Middle East & Africa Il-6 Inhibitors Market by Volume And Revenue
Recent Development in Il-6 Inhibitors Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "